Curasan AG operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Curasan AG with three other
pharmaceutical manufacturers in Europe:
sales of 8.73 million Euro [US$10.63 million]
of which 72%
was Research & Development Tax Credit),
Biomed Lublin Wytwornia Surowic I Szczepionek SA
(36.34 million Polish New Zlotys [US$10.63 million]
of which 76%
was Traditional Segment), and
Co Don AG
(5.60 million Euro [US$6.82 million]
of which 100%
was Product sales).
Curasan AG reported sales of 6.50 million Euro (US$7.92 million)
December of 2016.
increase of 15.8%
versus 2015, when the company's sales were 5.62 million Euro.